InvestorsHub Logo
Followers 594
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

Re: crush1128 post# 18326

Wednesday, 06/06/2012 2:24:39 PM

Wednesday, June 06, 2012 2:24:39 PM

Post# of 401559
Crush and Steges.

(1)The 1st Patent Grant 8,182,836 is for the Pharmacological Formulation of the polymer ( Eudragit 30D/40D)that sequesters and prevents the antagonist from leaking into the body before 3 days.

(2)The current 2nd Patent Application 12/640,344 is the 2-bead manufacturing technology that makes (1) work when the agonist opioid and the antagonist opioid are combined and taken together

I cannot yet think of any comparable technology to give an analogy. If I do I will post. The 2-bead technology is an essential unique technology in the history of pharmaceutical prescriptions.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News